These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2706738)

  • 1. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.
    Lawrence HJ; Walsh D; Zapotowski KA; Denham A; Goodnight SH; Gandara DR
    Cancer Chemother Pharmacol; 1989; 23(5):316-8. PubMed ID: 2706738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation.
    Olver IN; Aisner J; Hament A; Buchanan L; Bishop JF; Kaplan RS
    J Clin Oncol; 1988 Nov; 6(11):1732-5. PubMed ID: 3183703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity to topical dimethyl sulfoxide in a pediatric patient with anthracycline extravasation.
    Llinares ME; Bermúdez M; Fuster JL; Diaz MS; Gonzalez CM
    Pediatr Hematol Oncol; 2005; 22(1):49-52. PubMed ID: 15770831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.
    Ludwig CU; Stoll HR; Obrist R; Obrecht JP
    Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats.
    Uzunoglu S; Cosar R; Cicin I; Ibis K; Demiralay E; Benlier E; Erdogan B; Kandulu H; Ozen A; Altaner S
    J Plast Surg Hand Surg; 2013 Oct; 47(5):339-43. PubMed ID: 23710793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion.
    Comas D; Mateu J
    Ann Pharmacother; 1996 Mar; 30(3):244-6. PubMed ID: 8833558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of anthracycline extravasation injuries.
    Reeves D
    Ann Pharmacother; 2007 Jul; 41(7):1238-42. PubMed ID: 17550954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing skin damage induced by doxorubicin hydrochloride and daunorubicin hydrochloride.
    Cox RF
    Am J Hosp Pharm; 1984 Nov; 41(11):2410-4. PubMed ID: 6150636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes.
    Caballero Romero Á; Delgado Ureña MT; Salmerón García A; Megías Fernández MT; Librada Porriño-Bustamante M; Cabeza Barrera J
    Anticancer Drugs; 2018 Oct; 29(9):821-826. PubMed ID: 30036190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.
    Cabriales S; Bresnahan J; Testa D; Espina BM; Scadden DT; Ross M; Gill PS
    Oncol Nurs Forum; 1998; 25(1):67-70. PubMed ID: 9460774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
    Alberts DS; Dorr RT
    Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl sulfoxide for treating anthracycline extravasation.
    Rospond RM; Engel LM
    Clin Pharm; 1993 Aug; 12(8):560-1. PubMed ID: 8222519
    [No Abstract]   [Full Text] [Related]  

  • 17. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
    Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
    Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel extravasation.
    Berghammer P; Pöhnl R; Baur M; Dittrich C
    Support Care Cancer; 2001 Mar; 9(2):131-4. PubMed ID: 11305072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroids.
    Mitsuma A; Sawaki M; Shibata T; Morita S; Inada M; Shimokata T; Sugishita M; Kitagawa K; Sawada M; Nawa A; Ando Y
    Nagoya J Med Sci; 2012 Feb; 74(1-2):189-92. PubMed ID: 22515126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMSO and extravasation of mitomycin.
    Herrera D; Burnham N
    Oncol Nurs Forum; 1989; 16(2):155. PubMed ID: 2928263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.